High cholesterol levels, especially low-density lipoproteins (LDL), are one of the key risk factors for the development of atherosclerosis and subsequent cardiovascular diseases (CVD), such as myocardial infarction and stroke. These conditions pose a serious threat to health and life, requiring effective prevention and treatment strategies. Among the arsenal of medical drugs aimed at combating elevated cholesterol and its consequences, statins occupy a central place, demonstrating proven efficacy in reducing cardiovascular risk and improving prognosis for patients.
The Role of Cholesterol and the Mechanism of Action of Statins
Cholesterol is a fat-like substance necessary for cell construction, hormone production, and vitamin D synthesis. However, its excess, particularly in the form of LDL, can lead to accumulation on the walls of arteries, forming atherosclerotic plaques. This process, called atherosclerosis, narrows blood vessels, impedes blood flow, and increases the risk of thrombosis, which can lead to a heart attack or stroke.
Statins are a class of medications designed to effectively lower blood cholesterol levels. Their primary mechanism of action involves the inhibition of the HMG-CoA reductase enzyme, which plays a key role in cholesterol synthesis in the liver. By blocking the activity of this enzyme, statins significantly reduce the production of endogenous cholesterol, primarily low-density lipoproteins (LDL), often referred to as "bad" cholesterol. Lowering LDL levels helps prevent the formation of new atherosclerotic plaques and slows the progression of existing ones, thereby reducing the risk of serious cardiovascular complications.
In addition to their direct effect on cholesterol synthesis, statins also possess so-called pleiotropic effects, which include improving endothelial function (the inner lining of blood vessels), anti-inflammatory action, and stabilization of atherosclerotic plaques, making them less prone to rupture. These additional properties contribute to the comprehensive protective effect of statins on the cardiovascular system.
Proven Efficacy of Statins in CVD Prevention
Numerous clinical studies convincingly confirm the high efficacy of statins in the prevention and treatment of cardiovascular diseases. Specifically, statin therapy has demonstrated a clear and significant reduction in the risk of death and recurrent cardiac events in patients who have suffered acute coronary syndrome (ACS) or suffer from coronary artery disease (CAD) [3]. This is a critical aspect, as the prevention of recurrent events significantly improves the long-term prognosis and quality of life of patients.
Particular attention is paid to the role of statins in preventing heart failure after myocardial infarction (MI). Heart failure developing after MI is associated with increased in-hospital mortality and a worsened long-term prognosis [3]. Although there is some debate regarding the direct effect of statins on heart failure, the overall beneficial effects of statin therapy likely contribute to reducing the risk of developing this complication after myocardial infarction and ACS [3]. This means that statins not only effectively control cholesterol levels but also actively participate in protecting the heart from further damage and the development of serious complications after acute conditions.
Globally, there is a trend toward lower cholesterol levels in adults, for instance, in the USA [5], which emphasizes the importance of the widespread implementation of preventive measures and effective treatment, including statin therapy.
A Comprehensive Approach to Cardiovascular Risk Management
Effective management of cardiovascular risks requires a comprehensive and integrated approach, in which statins play a key, but not the only, role. It is important to consider other modifiable risk factors, such as blood pressure. Studies show that both intensive and standard treatment of arterial hypertension is essential for reducing the risk of cardiovascular disease and overall mortality, especially in adults with orthostatic hypotension [1]. This emphasizes the need for strict blood pressure control alongside cholesterol lowering.
Furthermore, in the context of coronary artery disease (CAD) and concurrent renal dysfunction, factors such as hyperhomocysteinemia (elevated homocysteine levels) are associated with increased arterial stiffness and markers of kidney injury [8]. In such complex clinical scenarios, statin therapy, along with the control of LDL cholesterol, arterial hypertension, and diabetes mellitus, is considered an integral part of comprehensive cardiovascular risk management [8].
In addition to drug treatment, lifestyle changes are of substantial importance. A balanced diet, regular physical activity, smoking cessation, and maintaining a healthy weight are fundamental components of CVD prevention. Only the combination of pharmacotherapy, including statins, with active lifestyle modification allows achieving the best and most sustainable results in the fight against cardiovascular diseases.
Safety of Statins and Recommendations for Use
Safety issues regarding statin therapy are the subject of ongoing scientific research and clinical discussion. Data reviews focusing on statins and their impact on the incidence of heart failure after myocardial infarction also include an analysis of mechanisms of action, safety, and clinical outcomes [3]. Overall, statins are considered safe and well-tolerated medications for the majority of patients when the dosage is properly selected and regular medical supervision is maintained.
Like any medication, statins can cause side effects, but their frequency and severity are usually low. The importance of regular monitoring by the attending physician lies in the timely detection and correction of potential adverse reactions. The decision to prescribe statins is always made individually, based on a careful assessment of the patient's overall cardiovascular risk, medical history, presence of comorbidities, and laboratory test results. Strict adherence to the doctor's recommendations regarding medication intake and regular follow-up examinations are the key to successful, effective, and safe therapy.
Conclusion
Statins remain a cornerstone in the strategy of cholesterol lowering and cardiovascular disease prevention. Their proven efficacy in reducing the risk of death, recurrent cardiac events, and preventing heart failure after myocardial infarction makes them indispensable for many patients. Combined with the control of other risk factors and a healthy lifestyle, statins significantly improve prognosis and quality of life, helping to prevent serious complications and preserve heart health for years to come.
Sources
- [1] Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Data Meta-Analysis. (JAMA, 2023) https://pubmed.ncbi.nlm.nih.gov/37847274/
- [3] Statins in the prevention of heart failure after myocardial infarction. (Current heart failure reports, 2009) https://pubmed.ncbi.nlm.nih.gov/19948089/
- [5] Cardiovascular diseases. (JAMA, 1994) https://pubmed.ncbi.nlm.nih.gov/8182837/
- [8] Association of Homocysteine with Arterial Stiffness and Biomarkers of Kidney Injury in Patients with Suspected Coronary Artery Disease. (Journal of clinical medicine, 2026) https://pubmed.ncbi.nlm.nih.gov/42452423/
Disclaimer: The information in this article is for reference purposes only and does not constitute a guide to self-treatment. Before starting any treatment or changing your current therapy, be sure to consult a qualified medical professional.